Summary of all the Indicators
Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relmada Therapeutics Inc’s (4E2) Moving Averages Convergence Divergence (MACD) indicator is -0.22, suggesting Relmada Therapeutics Inc is a Sell.
Relmada Therapeutics Inc’s (4E2) 20-Day exponential moving average is 3.92, while Relmada Therapeutics Inc’s (4E2) share price is €4.4, making it a Sell.
Relmada Therapeutics Inc’s (4E2) 50-Day exponential moving average is 4.36, while Relmada Therapeutics Inc’s (4E2) share price is €4.4, making it a Sell.
Relmada Therapeutics (4E2) Pivot Points
Classic
3.77
3.79
3.81
3.83
3.85
3.87
3.89
Fibonacci
3.79
3.80
3.81
3.83
3.84
3.85
3.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Relmada Therapeutics (4E2) Moving Averages
MA5
3.69Sell
3.72Sell
MA10
3.75Sell
3.77Sell
MA20
3.85Sell
3.92Sell
MA50
4.50Sell
4.36Sell
MA100
5.15Sell
4.62Sell
MA200
4.58Sell
4.12Sell
Relmada Therapeutics Inc’s (4E2) 10-Day exponential moving average is 3.77, while Relmada Therapeutics Inc’s (4E2) share price is €4.4, making it a Sell.
Relmada Therapeutics Inc’s (4E2) 100-Day exponential moving average is 4.62, while Relmada Therapeutics Inc’s (4E2) share price is €4.4, making it a Sell.
Relmada Therapeutics Inc’s (4E2) stock price is €4.4 and Relmada Therapeutics Inc’s (4E2) 50-day simple moving average is 4.50, creating a Sell signal.
Relmada Therapeutics Inc’s (4E2) stock price is €4.4 and Relmada Therapeutics Inc’s (4E2) 100-day simple moving average is 5.15, creating a Sell signal.
Relmada Therapeutics Inc’s (4E2) stock price is €4.4 and Relmada Therapeutics Inc’s (4E2) 200-day simple moving average is 4.58, creating a Sell signal.
Relmada Therapeutics (4E2) Technical Indicators
RSI (14)
35.73
Neutral
STOCH (9,6)
50.25
Neutral
STOCHRSI (14)
26.98
Neutral
MACD (12,26)
-0.22
Sell
ADX (14)
24.91
Neutral
Williams %R
-95.24
Buy
CCI (14)
-116.50
Buy
ATR (14)
0.11
-
Ultimate Oscillator
34.17
Neutral
ROC
-9.90
Sell
Relmada Therapeutics Inc’s (4E2) Relative Strength Index (RSI) is 35.73, creating a Neutral signal.
Relmada Therapeutics Inc’s (4E2) Trend Strength Indicator (ADX) is 24.91, creating a Neutral signal.
Relmada Therapeutics Inc’s (4E2) Commodity Channel Index (CCI) is -116.50, creating a Buy signal.
Relmada Therapeutics Inc’s (4E2) Price Rate of Change (ROC) is -9.90, creating a Sell signal.
FAQ
Is 4E2 a Buy, Hold, or Sell?
Based on 4E2’s technical indicators, 4E2 is a Strong Sell.
What is 4E2’s RSI (14)?
4E2’s RSI (14) is 35.73, which suggests 4E2 is a Neutral.
What is 4E2’s MACD?
4E2’s MACD is -0.22, which suggests 4E2 is a Sell.
What is 4E2’s 5-day moving average?
4E2’s 5-day moving average is 3.69, which suggests 4E2 is a Sell.
What is 4E2’s 20-day moving average?
4E2 20-day moving average is 3.85, which suggests 4E2 is a Sell.
What is 4E2’s 50-day moving average?
4E2’s 50-day moving average is 4.50, which suggests 4E2 is a Sell.
What is 4E2’s 200-day moving average?
4E2’s 200-day moving average is 4.58, which suggests 4E2 is a Sell.
What is 4E2’s Williams % R (14)?
4E2’s Williams % R (14) is -95.24, which suggests 4E2 is a Buy.
What is 4E2’s CCI (14)?
4E2’s CCI (14) is -116.50, which suggests 4E2 is a Buy.
What is the share price of Relmada Therapeutics Inc?
Relmada Therapeutics's share price is N/A€.